Rohto Pharmaceutical Ratios and Metrics

Market cap in millions EUR. Fiscal year is April - March.

Millions EUR. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb '26 Feb 19, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Market Capitalization	2,943	3,122	4,148	4,375	3,125	2,595
Market Cap Growth	-21.86%	-24.73%	-5.20%	40.03%	20.41%	-9.13%
Enterprise Value	2,916	3,049	3,742	3,986	2,821	2,288
PE Ratio	15.68	16.30	21.88	23.96	20.05	20.12
PS Ratio	1.61	1.64	2.50	2.65	2.11	1.86
PB Ratio	1.78	1.86	2.74	2.94	2.29	2.15
P/TBV Ratio	2.63	2.48	2.86	3.16	2.49	2.27
P/FCF Ratio	-	18.16	25.77	28.15	24.82	29.84
P/OCF Ratio	-	13.69	19.77	20.43	15.47	16.84
EV/Sales Ratio	1.58	1.60	2.26	2.41	1.91	1.64
EV/EBITDA Ratio	9.36	9.56	12.50	13.93	10.61	10.38
EV/EBIT Ratio	13.18	12.83	15.20	17.17	13.50	13.58
EV/FCF Ratio	-	17.73	23.25	25.64	22.41	26.31
Debt / Equity Ratio	0.17	0.19	0.04	0.05	0.12	0.05
Debt / EBITDA Ratio	0.92	0.97	0.21	0.28	0.60	0.28
Debt / FCF Ratio	-	1.80	0.40	0.52	1.26	0.72
Net Debt / Equity Ratio	-0.07	-0.10	-0.32	-0.32	-0.28	-0.29
Net Debt / EBITDA Ratio	-0.39	-0.52	-1.61	-1.65	-1.43	-1.57
Net Debt / FCF Ratio	-	-0.97	-3.00	-3.04	-3.03	-3.97
Asset Turnover	0.78	0.80	0.83	0.82	0.80	0.82
Inventory Turnover	2.31	2.47	2.59	2.72	2.71	2.55
Quick Ratio	1.35	1.55	1.82	1.75	1.74	1.79
Current Ratio	2.03	2.30	2.47	2.37	2.30	2.36
Return on Equity (ROE)	12.20%	11.94%	13.59%	13.25%	12.42%	11.31%
Return on Assets (ROA)	5.80%	6.26%	7.66%	7.17%	7.04%	6.20%
Return on Invested Capital (ROIC)	11.04%	13.63%	19.28%	18.52%	17.47%	14.91%
Return on Capital Employed (ROCE)	11.40%	11.80%	15.50%	14.60%	13.90%	12.90%
Earnings Yield	6.38%	6.13%	4.57%	4.17%	4.99%	4.97%
FCF Yield	-	5.51%	3.88%	3.55%	4.03%	3.35%
Payout Ratio	2492.43%	22.81%	17.70%	17.73%	16.28%	17.71%
Buyback Yield / Dilution	-1.58%	-0.04%	0.00%	0.00%	-	-0.01%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.